Literature DB >> 7927785

Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.

M Ninomiya1, O Matsushita, J Minami, H Sakamoto, M Nakano, A Okabe.   

Abstract

Clostridium perfringens type A strains which differed in alpha-toxin (phospholipase C [PLC]) productivity were inoculated intraperitoneally or intravenously into mice, and then their 50% mouse lethal doses (LD50) were determined. Strain NCTC 8237 produced ninefold higher PLC activity than strain 13. The mean LD50 for the former was 1 log unit lower than that for the latter. Two isogenic strains were constructed from strain 13: strain 13(pJIR418 alpha) (pJIR418 alpha contains the plc gene), which produced ninefold higher PLC activity than strain 13; and strain 13 PLC-, which showed no PLC productivity at all because of transformation-mediated gene disruption. The mean LD50 for strain 13(pJIR418 alpha) was 1 log unit lower than those for strain 13 PLC- and strain 13. These results indicate that PLC functions as a virulence-determining factor when it is produced in a sufficient amount. Such a difference in LD50 was also observed between Bacillus subtilis with and without the cloned plc gene. Inoculation of B. subtilis PLC+ intravenously into mice caused marked thrombocytopenia and leukocytosis. Mice inoculated with B. subtilis at 2 LD50 died because of circulatory collapse. Histological examination revealed that intravascular coagulation and vascular congestion occurred most prominently in the lungs. These results suggest that PLC plays a key role in the systemic intoxication of clostridial myonecrosis, probably by affecting the functions of platelets and phagocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927785      PMCID: PMC303223          DOI: 10.1128/iai.62.11.5032-5039.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12.

Authors:  R K Appleyard
Journal:  Genetics       Date:  1954-07       Impact factor: 4.562

2.  Effect of Clostridium perfringens phospholipase C(alpha-toxin) on the human diploid fibroblast membrane.

Authors:  R Möllby; M Thelestam; T Wadström
Journal:  J Membr Biol       Date:  1974       Impact factor: 1.843

3.  Studies on extracellular proteins from Staphylococcus aureus. VII. Studies on -haemolysin.

Authors:  T Wadström; R Möllby
Journal:  Biochim Biophys Acta       Date:  1971-07-21

4.  An upstream regulatory sequence stimulates expression of the perfringolysin O gene of Clostridium perfringens.

Authors:  T Shimizu; A Okabe; J Minami; H Hayashi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.

Authors:  J S Spika; P K Peterson; B J Wilkinson; D E Hammerschmidt; H A Verbrugh; J Verhoef; P G Quie
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

6.  Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism.

Authors:  Y Fujii; J Sakurai
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.

Authors:  D L Stevens; B E Troyer; D T Merrick; J E Mitten; R D Olson
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

8.  The virR gene, a member of a class of two-component response regulators, regulates the production of perfringolysin O, collagenase, and hemagglutinin in Clostridium perfringens.

Authors:  T Shimizu; W Ba-Thein; M Tamaki; H Hayashi
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

9.  Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.

Authors:  S Houldsworth; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.

Authors:  J Van Damme; J Van Beeumen; G Opdenakker; A Billiau
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  11 in total

1.  Clostridium sordellii phospholipase C: gene cloning and comparison of enzymatic and biological activities with those of Clostridium perfringens and Clostridium bifermentans phospholipase C.

Authors:  Tadahiro Karasawa; Xingmin Wang; Tsuneo Maegawa; Yoshio Michiwa; Hiroyuki Kita; Koichi Miwa; Shinichi Nakamura
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Development and application of a method for counterselectable in-frame deletion in Clostridium perfringens.

Authors:  Hirofumi Nariya; Shigeru Miyata; Motoo Suzuki; Eiji Tamai; Akinobu Okabe
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

3.  A Method for Purification of Clostridium perfringens Phospholipase C from Recombinant Bacillus subtilis Cells.

Authors:  Y Hirata; J Minami; M Koyama; O Matsushita; S Katayama; F Jin; H Maeta; A Okabe
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

4.  Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens.

Authors:  I Guillouard; T Garnier; S T Cole
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.

Authors:  J D Firth; E E Putnins; H Larjava; V J Uitto
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.

Authors:  A Gomez; A Mve-Obiang; B Vray; W Rudnicka; I C Shamputa; F Portaels; W M Meyers; P A Fonteyne; L Realini
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.

Authors:  David K O'Brien; Stephen B Melville
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi.

Authors:  K Tsutsui; J Minami; O Matsushita; S Katayama; Y Taniguchi; S Nakamura; M Nishioka; A Okabe
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

Review 9.  Perfringolysin O: The Underrated Clostridium perfringens Toxin?

Authors:  Stefanie Verherstraeten; Evy Goossens; Bonnie Valgaeren; Bart Pardon; Leen Timbermont; Freddy Haesebrouck; Richard Ducatelle; Piet Deprez; Kristin R Wade; Rodney Tweten; Filip Van Immerseel
Journal:  Toxins (Basel)       Date:  2015-05-14       Impact factor: 4.546

10.  Protection Efficacy of Oral Bait Probiotic Vaccine Constitutively Expressing Tetravalent Toxoids against Clostridium perfringens Exotoxins in Livestock (Rabbits).

Authors:  Jing Bai; Xinyuan Qiao; Yingying Ma; Meijing Han; Shuo Jia; Xinning Huang; Bing Han; Li Wang; Yijing Li; Yigang Xu
Journal:  Vaccines (Basel)       Date:  2020-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.